The OBD results on predictive biomarkers for treatment of rheumatoid arthritis patients will be presented in a talk by Dr Carl Goodyear (Glasgow University) at The American College of Rheumatology Conference in San Francisco. The study is co-authored with The Scottish Early Rheumatoid Arthritis Consortium, Professor Iain McInnes, Glasgow University and Professor Claudio Carini, Global Head of Biomarkers, Pfizer.